The peculiar clinical, histomorphological and biological characteristics of PMBCL are reviewed. Special emphasis is given to the frequent aggressive clinical behaviour of this lymphoma in which conventional prognostic factors seem inadequate to identify high risk cases. The need for new clinical and/or biological prognostic markers is stressed.
|Number of pages||9|
|Journal||Leukemia and Lymphoma|
|Issue number||SUPPL. 1|
|Publication status||Published - 1997|
ASJC Scopus subject areas
- Cancer Research